Fractyl Health Statistics
Total Valuation
Fractyl Health has a market cap or net worth of $279.57 million. The enterprise value is $264.10 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Fractyl Health has 137.04 million shares outstanding. The number of shares has increased by 65.30% in one year.
| Current Share Class | 137.04M |
| Shares Outstanding | 137.04M |
| Shares Change (YoY) | +65.30% |
| Shares Change (QoQ) | +31.83% |
| Owned by Insiders (%) | 1.33% |
| Owned by Institutions (%) | 58.38% |
| Float | 111.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 93,190.22 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 88,032.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.27
| Current Ratio | 4.27 |
| Quick Ratio | 4.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -518.40% and return on invested capital (ROIC) is -71.65%.
| Return on Equity (ROE) | -518.40% |
| Return on Assets (ROA) | -51.17% |
| Return on Invested Capital (ROIC) | -71.65% |
| Return on Capital Employed (ROCE) | -103.30% |
| Revenue Per Employee | $28 |
| Profits Per Employee | -$1.14M |
| Employee Count | 107 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.42% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -6.42% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 82.22 |
| Average Volume (20 Days) | 3,302,468 |
Short Selling Information
The latest short interest is 7.14 million, so 5.21% of the outstanding shares have been sold short.
| Short Interest | 7.14M |
| Short Previous Month | 7.23M |
| Short % of Shares Out | 5.21% |
| Short % of Float | 6.41% |
| Short Ratio (days to cover) | 4.40 |
Income Statement
In the last 12 months, Fractyl Health had revenue of $3,000 and -$122.20 million in losses. Loss per share was -$2.31.
| Revenue | 3,000 |
| Gross Profit | 3,000 |
| Operating Income | -98.74M |
| Pretax Income | -122.20M |
| Net Income | -122.20M |
| EBITDA | -97.67M |
| EBIT | -98.74M |
| Loss Per Share | -$2.31 |
Full Income StatementBalance Sheet
The company has $77.66 million in cash and $62.18 million in debt, giving a net cash position of $15.47 million or $0.11 per share.
| Cash & Cash Equivalents | 77.66M |
| Total Debt | 62.18M |
| Net Cash | 15.47M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | -3.18M |
| Book Value Per Share | -0.02 |
| Working Capital | 61.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$86.03 million and capital expenditures -$787,000, giving a free cash flow of -$86.81 million.
| Operating Cash Flow | -86.03M |
| Capital Expenditures | -787,000 |
| Free Cash Flow | -86.81M |
| FCF Per Share | -$0.63 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -3,291,400.00% |
| Pretax Margin | -4,073,233.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Fractyl Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -65.30% |
| Shareholder Yield | -65.30% |
| Earnings Yield | -43.71% |
| FCF Yield | -31.05% |
Analyst Forecast
The average price target for Fractyl Health is $7.40, which is 262.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.40 |
| Price Target Difference | 262.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 314.36% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Fractyl Health has an Altman Z-Score of -8.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.04 |
| Piotroski F-Score | 2 |